Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis

Estrogen receptor (ER)-positive breast cancer is the main subtype of breast cancer (BRCA) with high incidence and mortality. Andrographolide (AD), a major active component derived from the traditional Chinese medicine Andrographis paniculate, has substantial anti-cancer effect in various tumors. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tong, Jiang, Yanyu, Yuan, Shuying, Zhang, Li, Chen, Xihui, Zhao, Weili, Cai, Lili, Xiao, Biying, Jia, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124841/
https://www.ncbi.nlm.nih.gov/pubmed/35615146
http://dx.doi.org/10.3389/fonc.2022.899402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124841/
https://www.ncbi.nlm.nih.gov/pubmed/35615146
http://dx.doi.org/10.3389/fonc.2022.899402

Ejemplares similares